Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2018 1
2019 4
2020 2
2021 1
2022 3
2023 3
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean michael ortiz films (1 results)?
Relapsed rhabdoid tumours and other non-nephroblastoma childhood and adolescent kidney tumours: perspectives from the HARMONICA collaboration.
Ortiz MV, Wens FSPL, Hong AL, Quarello P, Verschuur AC, Tracy ET, Daw NC, Dome JS, Walz AL, Sprokkerieft J, Tytgat GAM, Kentsis A, Libes-Bander J, Schoettler PJ, Perotti D, Drost J, Venkatramani R, Geller JI, van den Heuvel-Eibrink MM. Ortiz MV, et al. Nat Rev Urol. 2026 Jan 2. doi: 10.1038/s41585-025-01117-4. Online ahead of print. Nat Rev Urol. 2026. PMID: 41478859 Review.
Paediatric kidney tumours are generally associated with a favourable survival rate. Most children are diagnosed with Wilms tumour, which has a 90% long-term survival rate with conventional front-line and salvage therapies. ...Several of these non-Wilms tumours inclu …
Paediatric kidney tumours are generally associated with a favourable survival rate. Most children are diagnosed with Wilms tumour, wh …
Case Report: First report of a Wilms tumor in an individual with Dias-Logan syndrome (BCL11A-related intellectual disability).
Troullioud Lucas AG, Fiala E, Razeq A, Sauerhaft T, Price AP, Mosquera JM, Miyauchi J, Gao M, Walsh MF, Ortiz MV. Troullioud Lucas AG, et al. Among authors: ortiz mv. Front Oncol. 2025 Jul 23;15:1585492. doi: 10.3389/fonc.2025.1585492. eCollection 2025. Front Oncol. 2025. PMID: 40772033 Free PMC article.
We report the first instance of a child with DLS diagnosed with cancer, a Wilms tumor (WT), who is notably much older than the typical onset. Although this case alone is insufficient to warrant routine WT screening in DLS, given the extreme rarity, we cannot rule out an as …
We report the first instance of a child with DLS diagnosed with cancer, a Wilms tumor (WT), who is notably much older than the typica …
Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor.
Groisser A, Frantz A, Geller JI, Ortiz MV, Walterhouse D, Ranalli M, Woods-Swafford W, Schoettler P, Garrington T, Mullen EA, Ash S, Bardhan P, Balis F, Dome JS. Groisser A, et al. Among authors: ortiz mv. Pediatr Blood Cancer. 2025 Oct;72(10):e31915. doi: 10.1002/pbc.31915. Epub 2025 Jul 25. Pediatr Blood Cancer. 2025. PMID: 40714994
BACKGROUND: The Pediatric Oncology Group P9262 Phase 2 study of single-agent paclitaxel demonstrated one complete response (CR), one partial response (PR), and four with stable disease (SD) among 15 patients with recurrent Wilms tumor (WT). Based on this activity, paclitax …
BACKGROUND: The Pediatric Oncology Group P9262 Phase 2 study of single-agent paclitaxel demonstrated one complete response (CR), one partial …
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers.
Perotti D, O'Sullivan MJ, Walz AL, Davick J, Al-Saadi R, Benedetti DJ, Brzezinski J, Ciceri S, Cost NG, Dome JS, Drost J, Evageliou N, Furtwängler R, Graf N, Maschietto M, Mullen EA, Murphy AJ, Ortiz MV, van der Beek JN, Verschuur A, Wegert J, Williams R, Spreafico F, Geller JI, van den Heuvel-Eibrink MM, Hong AL. Perotti D, et al. Among authors: ortiz mv. Nat Rev Urol. 2025 Aug;22(8):526-543. doi: 10.1038/s41585-024-00993-6. Epub 2025 Jan 29. Nat Rev Urol. 2025. PMID: 39881003 Review.
Approximately 20% of paediatric and adolescent/young adult patients with renal tumours are diagnosed with non-Wilms tumour, a broad heterogeneous group of tumours that includes clear-cell sarcoma of the kidney, congenital mesoblastic nephroma, malignant rhabdoid tumour of …
Approximately 20% of paediatric and adolescent/young adult patients with renal tumours are diagnosed with non-Wilms tumour, a broad h …
Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.
Conte B, Casey DL, Tringale KR, LaQuaglia MP, Gerstle JT, Wexler L, Ortiz MV, Wolden SL. Conte B, et al. Among authors: ortiz mv. Pediatr Blood Cancer. 2024 Jun;71(6):e30949. doi: 10.1002/pbc.30949. Epub 2024 Mar 22. Pediatr Blood Cancer. 2024. PMID: 38520048 Free PMC article.
The most common histologies included rhabdomyosarcoma (n = 42), Ewing sarcoma (n = 10), and Wilms tumor (n = 9). Most (95%) received chemotherapy, 37% had prior external beam radiation therapy to the site of IORT, and 46% had a prior surgery for tumor resection. ...
The most common histologies included rhabdomyosarcoma (n = 42), Ewing sarcoma (n = 10), and Wilms tumor (n = 9). Most (95%) received …
Hallmark discoveries in the biology of Wilms tumour.
Perotti D, Williams RD, Wegert J, Brzezinski J, Maschietto M, Ciceri S, Gisselsson D, Gadd S, Walz AL, Furtwaengler R, Drost J, Al-Saadi R, Evageliou N, Gooskens SL, Hong AL, Murphy AJ, Ortiz MV, O'Sullivan MJ, Mullen EA, van den Heuvel-Eibrink MM, Fernandez CV, Graf N, Grundy PE, Geller JI, Dome JS, Perlman EJ, Gessler M, Huff V, Pritchard-Jones K. Perotti D, et al. Among authors: ortiz mv. Nat Rev Urol. 2024 Mar;21(3):158-180. doi: 10.1038/s41585-023-00824-0. Epub 2023 Oct 17. Nat Rev Urol. 2024. PMID: 37848532 Review.
Since then, the efforts of researchers worldwide have substantially expanded our knowledge of Wilms tumour biology, including major advances in genetics - from cloning the first Wilms tumour gene to high-throughput studies that have revealed the genetic landscape of …
Since then, the efforts of researchers worldwide have substantially expanded our knowledge of Wilms tumour biology, including major a …
Advances in the clinical management of high-risk Wilms tumors.
Ortiz MV, Koenig C, Armstrong AE, Brok J, de Camargo B, Mavinkurve-Groothuis AMC, Herrera TBV, Venkatramani R, Woods AD, Dome JS, Spreafico F. Ortiz MV, et al. Pediatr Blood Cancer. 2023 May;70 Suppl 2(Suppl 2):e30342. doi: 10.1002/pbc.30342. Pediatr Blood Cancer. 2023. PMID: 37096797 Free PMC article. Review.
Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. ...
Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival …
Advances in the clinical management of high-risk Wilms tumors.
Ortiz MV, Koenig C, Armstrong AE, Brok J, de Camargo B, Mavinkurve-Groothuis AMC, Herrera TBV, Venkatramani R, Woods AD, Dome JS, Spreafico F. Ortiz MV, et al. Pediatr Blood Cancer. 2023 Mar;70(3):e30153. doi: 10.1002/pbc.30153. Epub 2023 Jan 10. Pediatr Blood Cancer. 2023. PMID: 36625399 Review.
Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival rate is approximately 50% or lower. ...
Outcomes are excellent for the majority of patients with Wilms tumors (WT). However, there remain WT subgroups for which the survival …
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors.
Coutinho DF, Mundi PS, Marks LJ, Burke C, Ortiz MV, Diolaiti D, Bird L, Vallance KL, Ibáñez G, You D, Long M, Rosales N, Grunn A, Ndengu A, Siddiquee A, Gaviria ES, Rainey AR, Fazlollahi L, Hosoi H, Califano A, Kung AL, Dela Cruz FS. Coutinho DF, et al. Among authors: ortiz mv. Med. 2022 Nov 11;3(11):774-791.e7. doi: 10.1016/j.medj.2022.09.002. Epub 2022 Oct 3. Med. 2022. PMID: 36195086 Free PMC article.
BACKGROUND: Malignant rhabdoid tumors (MRTs) and Wilms' tumors (WTs) are rare and aggressive renal tumors of infants and young children comprising 5% of all pediatric cancers. ...
BACKGROUND: Malignant rhabdoid tumors (MRTs) and Wilms' tumors (WTs) are rare and aggressive renal tumors of infants and young childr …
17 results